Mobile Intervention Kit to Increase HIV/HCV Testing and Overdose Prevention Training

 描述(由申请人提供)：由于许多注射毒品(PWID)的人没有收到关于艾滋病毒或丙型肝炎病毒检测和预防或过量预防和反应培训的足够信息，我们建议开发一种流动干预试剂盒，从理论指导的视频内容库中提供基于技术的干预措施。第一次迭代将涉及过量预防和应对培训，以及艾滋病毒/丙型肝炎预防教育。随后的迭代将扩展内容库，以包括其他主题。物质滥用和精神卫生服务管理局将艾滋病毒、丙型肝炎病毒和过量预防/应对列为当前优先事项。疾病控制和预防中心同样注意到在向PWID提供服务时应对艾滋病毒和丙型肝炎病毒的重要性。然而，项目工作人员可能并不总是对所有主题都完全了解，并且可能不会以PWID能够完全理解的方式解释细节。我们建议的移动干预工具包(MIK)将解决这一未得到满足的服务需求，同时为计划工作人员和管理员创造价值。一个简单易用的菜单将使客户组织能够配置每台平板电脑，以展示关于以下方面的简短视频(每台约2分钟)：过量预防和应对；纳洛酮的正确使用；艾滋病毒/丙型肝炎病毒预防；以及艾滋病毒和丙型肝炎病毒检测过程的细节。这些视频可以单独提供，也可以任意组合提供。参与者查看材料后，MIK将自动向由数字健康授权维护的非现场、受密码保护的数据库发送完成报告，由SBC提交当前建议书。这些报告中未查明身份的数据将被提供给客户组织，然后客户组织可以与现有和潜在的资助者分享细节，以记录他们提供的服务。数字健康授权将收取使用MIK的滑动费用，并将为每份报告收取额外费用。我们的项目团队已经创建了NIH资助的基于技术的干预措施，以促进物质使用报告，并在大容量城市急诊部门的患者中增加艾滋病毒检测。患者，包括那些最初拒绝检测的患者，将我们基于技术的方法的隐私和清晰度作为他们最终接受艾滋病毒检测和更诚实地报告药物使用的原因。我们的团队还拥有在各种临床和非临床外展环境中为高需求的PWID提供服务的经验。此外，数字健康授权负责人So-Young oh和Ian David Aronson博士拥有10多年的合作开发技术产品的经验，包括为非营利性、商业性和大学环境中的客户开发基于视频的健康干预和其他数字内容。我们计划以此专业知识为基础：开发视频和软件，以促进场馆合适的视频选择和演示，以及用于收集数据和生成自动完成报告的后端系统；以及在为PWID服务的项目中进行初步可行性试验(n=30)。

 DESCRIPTION (provided by applicant): Because many people who inject drugs (PWID) do not receive adequate information about: HIV or HCV testing and prevention, or overdose prevention and response training, we propose to develop a Mobile Intervention Kit to deliver technology-based interventions from a library of theory-guided video content. The first iteration will address overdose prevention and response training, as well as HIV/HCV prevention education. Subsequent iterations will expand the content library to include additional subjects. The Substance Abuse and Mental Health Services Administration lists HIV, HCV, and overdose prevention/response as current priorities. The Centers for Disease Control and Prevention similarly note the importance of addressing HIV and HCV when providing services to PWID. However, program staff may not always be fully knowledgeable about all topics, and may not explain details in ways PWID can fully understand. Our proposed Mobile Intervention Kit (MIK) will address this unmet need for services, while creating value for program staff and administrators. An easy to use menu will enable client organizations to configure each tablet to present brief videos (approximately 2 minutes each) on: overdose prevention and response; the proper use of naloxone; HIV/HCV prevention; and the specifics of HIV and HCV test processes. These videos can be offered individually or in any combination. After a participant has viewed the materials, the MIK will automatically send a completion report to an off- site, password protected database maintained by Digital Health Empowerment, the SBC submitting the current proposal. De-identified data from these reports will be provided to client organizations, which can then share details with current and potential funders to document the services they provide. Digital Health Empowerment will charge a sliding fee to use the MIK, and will collect additional fees for each report. Our project team has created NIH-funded technology-based interventions to facilitate substance use reporting and increase HIV testing among patients in high volume, urban emergency departments. Patients, including those who initially declined testing, cited the privacy and clarity of our technology-based approach as reasons they ultimately accepted HIV testing and more honestly reported substance use. Our team also has experience delivering services to high-need PWID in various clinical and non-clinical outreach settings. Additionally, Digital Health Empowerment principals So-Young Oh and Ian David Aronson, Ph.D. have more than 10 years experience collaboratively developing technology products, including video-based health interventions and other digital content, for clients in non-profit, commercial, and universiy settings. We plan to build upon this expertise to: develop videos and software to facilitate venue appropriate video selection and presentation, along with a backend system to collect data and generate automated completion reports; and conduct a preliminary feasibility trial (n=30) at a program serving PWID.